|
ARL5A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6011000000058E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.222200E-04 |
| Normal-vs-Stage2 |
6.724800E-01 |
| Normal-vs-Stage3 |
2.884600E-03 |
| Normal-vs-Stage4 |
1.92010000010789E-07 |
| Stage1-vs-Stage2 |
3.023400E-01 |
| Stage1-vs-Stage3 |
3.593000E-01 |
| Stage1-vs-Stage4 |
8.522500E-03 |
| Stage2-vs-Stage3 |
1.374820E-01 |
| Stage2-vs-Stage4 |
2.459800E-02 |
| Stage3-vs-Stage4 |
2.929200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.165400E-04 |
| Normal-vs-AfricanAmerican |
1.22220011888885E-11 |
| Normal-vs-Asian |
8.751800E-02 |
| Caucasian-vs-AfricanAmerican |
2.37390000001891E-06 |
| Caucasian-vs-Asian |
8.607400E-01 |
| AfricanAmerican-vs-Asian |
9.816400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.33720000000815E-05 |
| Normal-vs-Female |
8.587600E-04 |
| Male-vs-Female |
7.443400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31019999999971E-05 |
| Normal-vs-Age(41-60Yrs) |
1.556380E-03 |
| Normal-vs-Age(61-80Yrs) |
3.413100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.976500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.490100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.021040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.718400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.631000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.835200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.651000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.678300E-03 |
| Normal-vs-Grade 2 |
5.624000E-02 |
| Normal-vs-Grade 3 |
3.48880000000662E-06 |
| Normal-vs-Grade 4 |
8.41970004827886E-09 |
| Grade 1-vs-Grade 2 |
1.330190E-01 |
| Grade 1-vs-Grade 3 |
8.075200E-01 |
| Grade 1-vs-Grade 4 |
1.485810E-01 |
| Grade 2-vs-Grade 3 |
6.143700E-02 |
| Grade 2-vs-Grade 4 |
2.014100E-04 |
| Grade 3-vs-Grade 4 |
6.480200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.023350E-01 |
| Normal-vs-ccB subtype |
5.984500E-03 |
| ccA subtype-vs-ccB subtype |
1.732780E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.302370E-02 |
| Normal-vs-N1 |
1.682410E-02 |
| N0-vs-N1 |
3.198200E-01 |
|
|
